Open AccessHigh-dose quetiapine and therapeutic monitoring
Author(s) -
Hervé Javelot,
Francis Rangoni,
Luisa Weiner,
Bruno Michel
Publication year - 2018
Publication title -
european journal of hospital pharmacy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.313
H-Index - 14
eISSN - 2047-9964
pISSN - 2047-9956
DOI - 10.1136/ejhpharm-2018-001605
Subject(s) - quetiapine , quetiapine fumarate , atypical antipsychotic , medicine , therapeutic drug monitoring , antipsychotic drug , antipsychotic , drug , therapeutic index , schizophrenia (object oriented programming) , anesthesia , pharmacology , psychiatry
Quetiapine is an atypical antipsychotic with a good safety profile permitting its administration beyond the maximum dose of 800 mg/day. We report the case of a patient with a resistant schizophrenia treated with high doses of quetiapine (up to 2000 mg/day) combined with drug monitoring and with favourable therapeutic response and tolerance.